• Submit an Opportunity
  • About Us
  • Nominate MPM
  • Advertise
  • Contact Us
  • Private Policy
Thursday, January 28, 2021
Medtunity
Advertisement
  • Home
  • Medical Opportunities
    • Competitions
    • Conferences
    • Grants/Awards
    • Scholarships
    • Workshops/Webinars
    • Internships
    • Calls/Proposals
    • Online Courses
  • MedT-Learn
  • Jobs
  • Post a job
  • Blog
    • Mediblog
    • MedT Live Series
    • MedT Person of the Month
  • Log In
  • Home
  • Medical Opportunities
    • Competitions
    • Conferences
    • Grants/Awards
    • Scholarships
    • Workshops/Webinars
    • Internships
    • Calls/Proposals
    • Online Courses
  • MedT-Learn
  • Jobs
  • Post a job
  • Blog
    • Mediblog
    • MedT Live Series
    • MedT Person of the Month
  • Log In
No Result
View All Result
Medtunity
No Result
View All Result
Home Mediblog

New Drug Moves Closer To Becoming First Treatment For Fragile X Syndrome

by medtunity
January 8, 2021
in Mediblog
New Drug Moves Closer To Becoming First Treatment For Fragile X Syndrome

A new drug discovered through a research collaboration between the University at Buffalo and Tetra Therapeutics took a major step toward becoming a first-in-class treatment for Fragile X Syndrome, a leading genetic cause of autism.

The drug, BPN14770, achieved positive topline results in a phase 2 clinical study. The innovative treatment improved cognitive function in adult male patients with Fragile X Syndrome.

Fragile X Syndrome is a genetic disorder for which there is no cure. It is the most commonly known cause of inherited intellectual disability, according to the Centers for Disease Control and Prevention.

“We are very excited about the results of this study,” said Mark Gurney, PhD, founder and chief executive officer of Tetra Therapeutics. “In addition to being safe and well tolerated, treatment with BPN14770 led to significant cognitive improvement, specifically in the language domains, and we also saw a clinically meaningful benefit in overall daily functioning. These findings validate our approach to treating this disease through a mechanism that addresses a core deficit in the disorder.”
 

The research was conducted at Rush University Medical Center by principal investigator and pediatric neurologist Elizabeth Berry-Kravis, MD, PhD Funding was provided by the FRAXA Research Foundation, a nonprofit dedicated to financing Fragile X Syndrome research.

Preclinical investigation of BPN14770 was completed through a collaboration between UB School of Pharmacy and Pharmaceutical Sciences faculty members James M. O’Donnell, PhD, dean and professor, and Ying Xu, MD, PhD, research associate professor, and biotechnology company Tetra Therapeutics.

The drug inhibits the activity of phosphodiesterase-4D, an enzyme that plays a key role in memory formation, learning, neuroinflammation and traumatic brain injury. Previous studies found that BPN14770 has the potential to promote the maturation of connections among neurons, which are impaired in patients with Fragile X Syndrome.

“The collaboration with Tetra Therapeutics has been interesting and productive, combining our lab’s expertise in preclinical pharmacology and theirs in drug discovery and development,” said O’Donnell. “Seeing years of research lead to a successful trial for treatment of this serious genetic disorder is quite rewarding.

” BPN14770’s potential to improve cognitive and memory function could also translate to treatments for Alzheimer’s disease, developmental disabilities, traumatic brain injury and schizophrenia.

Tags: discoverydiseasesdrugs
Share3Tweet2Send

Related Posts

FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV

FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV

by jessica
January 24, 2021
0
34

The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the...

10 top tips for grant applications

10 top tips for grant applications

by medtunity
January 15, 2021
0
34

1. Provide a clear hypothesis and key questions Make it clear at the start what you are planning to do,...

Unique Robot Assisted Surgical Microscope and Camera System

Unique Robot Assisted Surgical Microscope and Camera System

by medtunity
December 20, 2020
0
39

Ocular lenses, surgical microscopes and camera systems are reaching their limits in microsurgery. A start up company has invented a unique robot assisted surgical microscope and camera system that...

Drug May Boost Thinking Skills in People With Advanced MS

Drug May Boost Thinking Skills in People With Advanced MS

by medtunity
December 17, 2020
0
44

Researchers say a multiple sclerosis drug meant to slow physical disability also shows promise in improving mental acuity in people who are...

Chest drainage system can help reduce COVID-19 spread – research suggests

Chest drainage system can help reduce COVID-19 spread – research suggests

by medtunity
December 14, 2020
0
44

Research which reveals digital chest drains generate and distribute less aerosol generated particles compared to traditional water seal systems, has...

Spinal Cord Stimulation

Spinal Cord Stimulation

by medtunity
December 14, 2020
0
75

Have you ever wondered the next therapy for a patient who isn't responding to any of the pain management approach?....

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result
ADVERTISEMENT
Medtunity

Medtunity © 2020, All Right Reserved. |Designed by +234-907-202-7280|

Navigate Site

  • Log In
  • Medical Opportunities
  • Submit an Opportunity
  • Post a job
  • Nominate MPM
  • Private Policy

Follow Us

No Result
View All Result
  • Home
  • Medical Opportunities
    • Medical Opportunities
    • Competitions
    • Conferences
    • Grants/Awards
    • Internships
    • Scholarships
    • Online Courses
    • Workshops/Webinars
    • Submit an Opportunity
  • Jobs
  • Post a job
  • Blog
    • Mediblog
    • MedT Live Series
    • MedT Person of the Month
  • Contact Us
  • About Us
  • Log In

Medtunity © 2020, All Right Reserved. |Designed by +234-907-202-7280|

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist